Menadiol Diphosphoric Acid

Menadiol Diphosphoric Acid

SCHEMBL515181

Cc1cc(OP(=O)(O)O)c2ccccc2c1OP(=O)(O)O

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.51
INPPL1 O15357 9/20 0.50
INPP5A Q14642 5/20 0.50
INPP5B P32019 2/20 0.50
AKT1 P31749 1/20 0.48
SRC P12931 5/20 0.47
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 2/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
PDE3A Q14432 1/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
GPR84 Q9NQS5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4338968 0.82 HTT (0.58) HTTINPPL1INPP5AINPP5BAKT1
Menadiol Diphosphoric Acid SCHEMBL1005168 0.80 GPR84 (0.49) HTTSRCKDM4EHSD17B10ALDH1A1
SCHEMBL14398797 0.74 SRC (0.47) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL28295682 0.74 GPR84 (0.67) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL1100136 0.72 INPPL1 (0.57) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL8386747 0.72 INPPL1 (0.68) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL10438501 0.72 PLK1 (0.53) INPPL1INPP5AINPP5BAKT1SRC
SCHEMBL10915218 0.71 HTT (0.52) HTTSRCKDM4EHSD17B10TP53
O-Xylene SCHEMBL29031713 0.71 INPPL1 (0.55) INPPL1INPP5AINPP5BAKT1SRC
Hydrochloric Acid SCHEMBL11749404 0.71 INPPL1 (0.55) INPPL1INPP5AINPP5BAKT1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9212214-B2 Methods of increasing the expression yield of vitamin K-dependent proteins CSL LIMITED (AU) 2015-12-15 US claimed
US-20130261603-A1 TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS LUTONIX, INC. (US) 2013-10-03 US claimed
US-20130253475-A1 TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS LUTONIX, INC. (US) 2013-09-26 US claimed
US-20130197431-A1 DRUG RELEASING COATINGS FOR MEDICAL DEVICES LUTONIX, INC. (US) 2013-08-01 US claimed
US-20130197435-A1 MEDICAL DEVICE RAPID DRUG RELEASING COATINGS COMPRISING OILS, FATTY ACIDS, AND/OR LIPIDS LUTONIX, INC. (US) 2013-08-01 US claimed
US-20130189190-A1 MEDICAL DEVICE RAPID DRUG RELEASING COATINGS COMPRISING A THERAPEUTIC AGENT AND A CONTRAST AGENT LUTONIX, INC. (US) 2013-07-25 US claimed
US-20130189329-A1 DRUG RELEASING COATINGS FOR MEDICAL DEVICES LUTONIX, INC. (US) 2013-07-25 US claimed
US-8414526-B2 Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids LUTONIX, INC. (US) 2013-04-09 US claimed
US-8414525-B2 Drug releasing coatings for medical devices LUTONIX, INC. (US) 2013-04-09 US claimed
EP-2550030-A1 DRUG RELEASING COATINGS FOR MEDICAL DEVICES Lutonix, Inc. (US) 2013-01-30 EP claimed
US-20080276935-A1 TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS LUTONIX, INC. 2008-11-13 US claimed
US-20080255509-A1 MEDICAL DEVICE RAPID DRUG RELEASING COATINGS COMPRISING OILS, FATTY ACIDS, AND/OR LIPIDS LUTONIX, INC. 2008-10-16 US claimed
US-20080255508-A1 Such as balloon and stents; medical device with overcoating of drug with additive; bioavailability LUTONIX, INC. 2008-10-16 US claimed
US-20080255510-A1 Layer containing therapeutic agent, adjuvant and contrast agent ; high speed supplying agent to tissue; adjuvant contains hyfrophilic part and drug affinity part; overcoating exterior surface of medical device LUTONIX, INC. 2008-10-16 US claimed
US-20080175887-A1 drug delivering by oral, nasal or pulmonary administration, of rapamycin or paclitaxel drug; additive enhances absorption of drug into body tissue; PEG-fatty acids esters, PEG-fatty alcohol ethers, polyethylene glycol sorbitan fatty acid esters, polyoxyethylene-polyoxypropylene block copolymers LUTONIX, INC. 2008-07-24 US claimed
WO-2008063581-A2 TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS LUTONIX, INC. (US) 2008-05-29 WO claimed
WO-2008063576-A2 DRUG RELEASING COATINGS FOR MEDICAL DEVICES LUTONIX, INC. (US) 2008-05-29 WO claimed
US-20080118544-A1 Such as a balloon catheter or a stent; a drug not enclosed in micelles or encapsulated in particles or controlled release carriers and an additive having hydrophobic and hydrophilic portions; improved pharmacokinetics and bioavailability LUTONIX, INC. 2008-05-22 US claimed
EP-0998925-A1 MEDICINAL COMPOSITIONS FOR TOPICAL ADMINISTRATION CONTAINING VITAMIN D AND VITAMIN K New Vision Co., Ltd. (JP) 2000-05-10 EP claimed
US-5876709-A Ophthalmic composition containing active Vitamin D NEW VISION CO., LTD. (JP) 1999-03-02 US claimed